Eight genes in the model showed significant differences between LGG and GBM, including three regulators (EIF3A, IGF2BP3, YTHDC1) and five target genes (AK2, CYP17A1, EMP3, IGFBP2 and TUBA1C). The gene discussed is AK2; the disease is glioblastoma.